Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care

NARecruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 8, 2025

Primary Completion Date

April 7, 2026

Study Completion Date

October 2, 2026

Conditions
Opiate OverdoseOpioid-Related DisordersNarcotic-Related DisordersSubstance-related DisordersChemically-Induced DisordersMental Disorders
Interventions
BEHAVIORAL

Machine Learning-Based Clinical Decision Support: Overdose Prevention Alert (OPA) Intervention

In this study, researchers will pilot test an interruptive, ML CDS tool for opioid overdose risk across thirteen primary care clinics at the UF Health in Gainesville, FL. When a patient is identified by the ML algorithm as having an elevated overdose risk and a PCP signs an opioid prescription for the patient, an Opioid Prevention Alert (OPA) will be triggered. The alert will include the rationale for the patient's elevated risk status and provide three risk mitigation recommendations: optimizing pain treatment and mental health support, reviewing and discussing risks with the patient, and offering naloxone annually if no prior naloxone order is found in the patient's record. PCPs can also select an override reason, such as the patient already has naloxone, declined the intervention, is not present/it is not the right time, or the alert is not relevant/other comments, when appropriate.

Trial Locations (1)

32608

RECRUITING

University of Florida Health Internal Medicine and Family Medicine, Gainesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Applied Decision Science

UNKNOWN

lead

University of Pittsburgh

OTHER

NCT06810076 - Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care | Biotech Hunter | Biotech Hunter